2018 International Congress » Restless Legs Syndrome and Other Sleep Disorders
Date: Sunday, October 7, 2018
Time: 1:45pm-3:15pm
Location: Hall 3FG
Meeting: 2018 International Congress
- 1:45pm-3:15pm
-
Botulinum toxin in Restless Leg Syndrome – A Randomized Double-Blind Placebo-Controlled Study
- 1:45pm-3:15pm
-
Clonazepam for REM sleep behavior disorder in Parkinsonism: A randomized, placebo-controlled trial
- 1:45pm-3:15pm
-
Difference in sleep disorders among Parkinson’s disease, cervical dystonia and patients with depression
- 1:45pm-3:15pm
-
Eye tracking in patients with restless legs syndrome with and without augmentation – interim results of an ongoing study
- 1:45pm-3:15pm
-
Genetic Markers of Essential Tremor in Restless Legs Syndrome/Willis-Ekbom Disease in Southern Chinese Population
- 1:45pm-3:15pm
-
Incidence, prevalence and clinical features of sleep disorders in alphasynucleinopthies: A cohort study
- 1:45pm-3:15pm
-
Neurostructural alterations associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s disease
- 1:45pm-3:15pm
-
REM Sleep Behavior Disorder Associations with Parkinson’s Disease Study (RAPiDS): Initial Baseline Data
- 1:45pm-3:15pm
-
Restless legs syndrome as a first manifestation of cerebral stroke: Clinical analysis of 7 cases
- 1:45pm-3:15pm
-
Restless Legs Syndrome in Pregnant Thai Women: Prevalence, Natural History, and Risk Factors
- 1:45pm-3:15pm
-
Seasonal Fluctuation in a Chinese cohort of patients with idiopathic Restless Legs Syndrome
- 1:45pm-3:15pm
-
Sleep Abnormalities in patients with Parkinson’s disease having REM sleep behaviour disorder with and without Psychosis
- 1:45pm-3:15pm
-
The change of SIRT1 and HIF-1 in MPTP treated mouse